) enVista Envy™ — Full Range of Vision IOLs | Bausch + Lomb Surgical

Flourish at every step

Discover the Full Range of Vision IOL that launches a new era of confidence with enviable outcomes.¹

Remarkable performance in all lighting conditions with ActivSync – Intelligent energy distribution¹,² and excellent patient tolerance to glare, halos and starbursts.¹,³

 

Advanced enVista™ IOL platform features

TruSight™ technology: glistening-free material⁴

StableFlex™ technology: formulated for efficient unfolding

SureEdge™ design: for a low PCO rate⁵

Accuset™ Haptics: designed for refractive predictability and stable centration⁴,⁶

Full Range of Vision Optics

ActiveSync apodization, combined with proprietary smoothing technology, refines the diffractive profile to enhance optical performance by minimizing unwanted artifacts while preserving light distribution efficiency.⁷

By integrating a smoothed diffractive surface with a gradual reduction in step height (ActiveSync), the lens design optimizes diffraction efficiency, for improving contrast sensitivity under mesopic and large-pupil conditions and reducing visual disturbances.

Furthermore, the ActiveSync diffractive profile progressively attenuates peripheral diffractive contributions, ensuring a more uniform and balanced energy distribution across the optic. This advanced design provides surgeons with a technology for delivering both visual quality and consistency for a broad range of patients.

ActivSync optic delivers intelligent energy distribution

enVista Envy™ demonstrated excellent performance. In photopic conditions, ActivSync optic maintained excellent full range of vision for patients.¹ In pupils larger than 4 mm, ActivSync optic is able to prioritize light energy, without compromising visual acuity under mesopic conditions.¹

A lens with an enviable tolerance to dysphotopsia¹,³,⁸*

A full range of vision comes with high expectations. enVista Envy™ can enhance your patients’ visual experience in their daily-life activities³

 

Help your patients achieve spectacle independence¹

enVista Envy™ achieved excellent mean visual acuity results in a robust clinical study¹ and delivers continuous full range of vision spectacle independence¹

Patients achieving 20/32 Snellen (0.63 Decimal) or better Binocular Uncorrected Visual Acuity, 4–6 months post-op¹

 

Lock in rotational stability you can count on

Accuset™ Haptics – designed for refractive predictability and stable centration⁴,⁶,⁹

  • Fenestrated haptics to prevent transfer of stress from the haptic to the optic
  • Haptics designed to maximize the contact angle against the capsular bag

enVista™ Toric delivered proven rotational stability from visit 1-2 months to visit 4-6 months¹³. 100 % of eyes ≤ 5° rotation

 

Removing cataracts. Correcting astigmatism. Both at the same time.

Benefits of toric IOLs

  • Avoid the need to perform other procedures during cataract surgery
  • Shown to provide greater accuracy and range of corrective power than corneal incisional and limbal relaxing procedures¹⁴

A significant number of patients today are not treated for astigmatism, despite the need. A small amount of astigmatism (as little as 0.50 D) has the potential to affect functional and low contrast visual acuity and has an impact on the visual comfort of computer users.¹⁵

Thanks to our extended range of cyls and ultra low +0.90 D

enVista Envy™ Toric covers 68 % of the cataract surgery population with > +0.50 D of corneal astigmatism¹⁶*

Precise astigmatism correction with balanced cylinder steps:

  • Ultra low cylinder treatment: +0.90 D at IOL plane (+0.64 D at corneal plane)¹⁷
  • Maximum available cylinder treatment: +5.75 D at IOL plane (+0.64 D at corneal plane)¹⁷
  • Only toric platform that offers equal or less than half-step cylinders (up to +3.50 D at IOL plane)¹⁷

Technical Specifications

MATERIAL: Hydrophobic Acrylic
OPTIC DESIGN

  • One-piece
  • Aspheric, biconvex
  • Anterior apodized diffractive
  • Posterior refractive
  • Posterior aspheric surface
  • +1.6 D intermediate
  • +3.1 D near

OPTIC SIZE: 6 mm
LENGTH: 12.5 mm
OPTIC EDGE DESIGN: Sharp 360° square posterior edge
HAPTICS: Modified C, fenestrated
REFRACTIVE INDEX: 1.53 at 35° C
UV CUTOFF: 389 nm at 10 % transmittance
OPTICAL BIOMETRY:

  • Barrett Universal II: A-constant 119.28, LF 2.03
  • EVO 2.0: A-constant 119.24
  • Hill-RBF 3.0: Hill-RBF 3.0 A-constant 119.26
  • SRK/T: A-constant 119.25
  • Hoffer Q: pACD: 5.788
  • Holliday I: SF: 1.981
  • Haigis: a0: 0.871 a1: 0.143 a2: 0.165


OTHER FEATURES: Glistening free

DIOPTER RANGE:

  • enVista EnvyTM
    From +6.00 D to +34.00 D:
    • From +6.00 D to +10.00 D (1.00 D steps)
    • From +10.00 D to +34.00 D (0.50 D steps)
  • enVista EnvyTM TORIC
    Spherical equivalent power:
    From +6.00 D to +34.00 D (0.50 D steps)
  • Cylinder power – IOL Plane:
    +0.90 D / +1.25 D / +1.50 D / +2.00 D / +2.50 D /
    +3.00 D / +3.50 D / +4.25 D / +5.00 D / +5.75 D
  • Cylinder power - Corneal plane:
    +0.64 D / +0.90 D / +1.06 D / +1.40 D / +1.76 D /
    +2.11 D / +2.45 D / +2.98 D / +3.50 D / +4.03 D

DELIVERY SYSTEM
Non-preloaded
BLIS (screw type, controlled delivery) reusable
inserter and single use cartridge
Inserter: BLIS-R1 (1 Unit/box)
Cartridge: BLIS-X1 (10 Units/box)
Recommended incision size ≥ 2.2 mm
INJ100 (Silicone tip, push type single handed)
Single-use inserter (10 Units/box)
Recommended incision size ≥ 2.2 mm

Preloaded
EyeGilityTM inserter
(Silicone tip, push type single handed)
Single-use inserter
Recommended incision size ≥ 2.0 mm

* Constants are estimates only. It is recommended that each surgeon develops their own values.

 

ADDITIONAL PRODUCT INFORMATION

References

References

1. Mitchell C. Shultz , William F. Wiley , Eva Liang , Alice T. Epitropoulos , Jeffrey Whitman , Visual and patient-reported outcomes of a novel full visual range IOL versus a
monofocal IOL: A randomized multicenter US trial, American Journal of Ophthalmology (2025), doi: doi.org/10.1016/j.ajo.2025.08.050
2. R&D report: Optical Design Release for enVista Envy (MX60EF) IOL V16-070M1_Rev B (Aug 2023)
3. Muzychuk A. and Harasymowycz H.: Efficacy and Safety Evaluation of a New Full Visual Range versus Monofocal IOL in Cataract Patients: A Randomized, Controlled Canadian Clinical
Trial. JCRS (2025), doi: 10.1097/j.jcrs.0000000000001714
4. P. Heiner et al. Safety and effectiveness of a single-piece hydrophobic acrylic intraocular lens (enVista®) – results of a European and Asian-Pacific study. Clin Ophthalmol. 2014:8 629–635.
5. Ton Van C, Tran THC. Incidence of posterior capsular opacification requiring Nd:YAG capsulotomy after cataract surgery and implantation of enVista® MX60 IOL. J Fr Ophtalmol.
2018 Dec;41(10):899-90
6. Parker et al. Safety and effectiveness of a glistening-free single-piece hydrophobic acrylic intraocular lens (enVista). Clin Ophthalmol. 2013:7 1905–1912.
7. B+L_PRJ-000435238_Clear Path Technology_ Jan 30, 2025
8. Alcon AcrySoft PanOptix FDA SSED,https://www.accessdata.fda.gov/cdrh_docs/pdf4/P040020S087B.pdf. accessed 11-Mar-2025
9. Garzon et al. Evaluation of Visual Outcomes After Implantation of Monofocal and Multifocal Toric Intraocular Lenses. J Refract Surg. 2015;31(2):90-97.
10. BAUSCH + LOMB: Intraocular lens design verification report- July 2016.
11. BAUSCH + LOMB R&D Bench data: IOL competitive benchmarking study report_DEC 2009.
12. PMA P980040/S039: FDA Summary of Safety and Effectiveness Data_Tecnis Toric IOL.
13. enVista Toric data (MX60T). Packer M, Williams JI, Feinerman G, Hope RS. Prospective multicenter clinical trial to evaluate the safety and effectiveness of a new glistening-free
onepiece acrylic toric intraocular lens. Clinical Ophthalmology 2018:12 1031-1039
14. Lake JC, Victor G, Clare G, et al. Toric intraocular lens versus limbal relaxing incisions for corneal astigmatism after phacoemulsification. Cochrane Database Syst Rev.
2019;12(12):CD012801. doi: 10.1002/14651858. CD012801.pub2
15. Miller AD, Kris MJ, Griffiths AC. Effect of small focal errors on vision. Optom Vis Sci. 1997;74(7):521-526. Novis C. Astigmatism and Toric Intraocular Lenses. Current Opinion in
Ophthalmology 2000; Vol. 11, Issue 1: 47-50.
16. De Bernardo M, Zeppa L, Cennamo M, Iaccarino S, Zeppa L, Rosa N. Prevalence of Corneal Astigmatism before Cataract Surgery in Caucasian Patients. European Journal of
Ophthalmology. 2014;24(4):494-500. doi:10.5301/ejo.5000415
17. enVista Envy Toric Directions for Use, Bausch + Lomb.
18. Clareon PanOptix Directions for Use, Alcon.
19. Finevision HP Directions for Use
20. RayONE Trifocal Directions for Use, Rayner
21. TECNIS Synergy Directions for Use, Johnson & Johnson

Contact